Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Castelli

Showing results (261-270 of 425) with videos related to

Pageof 43
Sort By:
AIDS Care|June 21, 2016
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012Eugenia Quiros-Roldan, Elena Raffetti, Emanuele Focà, et al.
The New Microbiologica|March 3, 2020
Clinical management of imported malaria in Italy: results from a national cross-sectional survey in 2015Luciana Lepore, Francesco Vairo, Alessandra D'Abramo, et al.
AIDS (London, England)|April 18, 2003
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimensMaria Paola Trotta, Adriana Ammassari, Alessandro Cozzi-Lepri, et al.
AIDS and Behavior|March 6, 2022
Psychological and Emotional Impact of COVID-19 Pandemic on People Living with Chronic Disease: HIV and CancerEmanuele Focà, Chiara Fornari, Stefania Arsuffi, et al.
HIV Clinical Trials|December 26, 2002
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal studyAndrea Patroni, Carlo Torti, Lina Tomasoni, et al.
Current HIV Research|February 13, 2014
Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patientsSilvia Amadasi, Silvia Odolini, Emanuele Foca, et al.
Vaccine|January 25, 2014
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity studyMaria Luisa Iaria, Simona Fiorentini, Emanuele Focà, et al.
Andrology|March 9, 2026
SIEDY Diagnostic Accuracy in Assessing Erectile Dysfunction in Young Men Living With HIVGiorgio Tiecco, Federico Cesanelli, Cosimo Colangelo, et al.
AIDS (London, England)|September 10, 2002
Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patientsMario Clerici, Elena Seminari, Franco Maggiolo, et al.
HIV Medicine|January 3, 2023
Liver fibrosis may lower PSA levels: A further reason to be wary in prostate cancer screening in men with HIV?Maria Mazzitelli, Emanuele Foca', Mattia Prosperi, et al.
Pageof 43

Showing results (261-270 of 425) with videos related to

Sort By:
Pageof 43
AIDS Care|June 21, 2016
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012Eugenia Quiros-Roldan, Elena Raffetti, Emanuele Focà, et al.
The New Microbiologica|March 3, 2020
Clinical management of imported malaria in Italy: results from a national cross-sectional survey in 2015Luciana Lepore, Francesco Vairo, Alessandra D'Abramo, et al.
AIDS (London, England)|April 18, 2003
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimensMaria Paola Trotta, Adriana Ammassari, Alessandro Cozzi-Lepri, et al.
AIDS and Behavior|March 6, 2022
Psychological and Emotional Impact of COVID-19 Pandemic on People Living with Chronic Disease: HIV and CancerEmanuele Focà, Chiara Fornari, Stefania Arsuffi, et al.
HIV Clinical Trials|December 26, 2002
Effect of highly active antiretroviral therapy (HAART) and hepatitis C Co-infection on hyperlipidemia in HIV-infected patients: a retrospective longitudinal studyAndrea Patroni, Carlo Torti, Lina Tomasoni, et al.
Current HIV Research|February 13, 2014
Evaluation of boosted and unboosted atazanavir plasma concentration in HIV infected patientsSilvia Amadasi, Silvia Odolini, Emanuele Foca, et al.
Vaccine|January 25, 2014
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity studyMaria Luisa Iaria, Simona Fiorentini, Emanuele Focà, et al.
Andrology|March 9, 2026
SIEDY Diagnostic Accuracy in Assessing Erectile Dysfunction in Young Men Living With HIVGiorgio Tiecco, Federico Cesanelli, Cosimo Colangelo, et al.
AIDS (London, England)|September 10, 2002
Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patientsMario Clerici, Elena Seminari, Franco Maggiolo, et al.
HIV Medicine|January 3, 2023
Liver fibrosis may lower PSA levels: A further reason to be wary in prostate cancer screening in men with HIV?Maria Mazzitelli, Emanuele Foca', Mattia Prosperi, et al.
Pageof 43